Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Intl J Cancer. 2008, 2010 (127): 2893-917.
Google Scholar
Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med. 2003, 349: 2241-52. 10.1056/NEJMra035010.
Article
CAS
PubMed
Google Scholar
Holmes RS, Vaughan TL: Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007, 17: 2-9. 10.1016/j.semradonc.2006.09.003.
Article
PubMed
Google Scholar
La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F: Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol. 2010, 21: 1323-60. 10.1093/annonc/mdp530.
Article
CAS
PubMed
Google Scholar
Stoner GD, Gupta A: Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis. 2001, 22: 1737-1746. 10.1093/carcin/22.11.1737.
Article
CAS
PubMed
Google Scholar
Ilson DH: Esophageal cancer chemotherapy: recent advances. Gastrointest Cancer Res. 2008, 2: 85-92.
PubMed
PubMed Central
Google Scholar
Siddik ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003, 22: 7265-7279. 10.1038/sj.onc.1206933.
Article
CAS
PubMed
Google Scholar
Arn’er ESJ, Nakamura H, Sasada T, Yodoi J, Holmgren A, Spyrou G: Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite the glutathione-platinum complex. Free Rad Biol Med. 2001, 31 (10): 1170-1178. 10.1016/S0891-5849(01)00698-0.
Article
Google Scholar
Ishikawa T: The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci. 1992, 17: 463-468. 10.1016/0968-0004(92)90489-V.
Article
CAS
PubMed
Google Scholar
Tew WP, Kelsen DP, Ilson DH: Targeted therapies for esophageal cancer. Oncologist. 2005, 10: 590-601. 10.1634/theoncologist.10-8-590.
Article
CAS
PubMed
Google Scholar
Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H: Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes. 2005, 54: 2404-2414.
Article
PubMed
Google Scholar
Prager R, Schernthaner G, Graf H: Effect of metformin on peripheral insulin sensitivity in non-insulin dependent diabetes mellitus. Diabetes Metab. 1986, 12: 346-350.
CAS
Google Scholar
Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD: Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005, 330: 1304-1305. 10.1136/bmj.38415.708634.F7.
Article
PubMed
PubMed Central
Google Scholar
Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M: Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006, 66: 10269-10273. 10.1158/0008-5472.CAN-06-1500.
Article
CAS
PubMed
Google Scholar
Sahra IB: The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells. Autophagy. 2010, 6: 670-671. 10.4161/auto.6.5.12434.
Article
PubMed
Google Scholar
Kato K, Gong J, Iwama H, Kitanaka A, Tani J, Miyoshi H, Nomura K, Mimura S, Kobayashi M, Aritomo Y, Kobara H, Mori H, Himoto T, Okano K, Suzuki Y, Murao K, Masaki T: The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Mol Cancer Ther. 2012, 11: 549-60. 10.1158/1535-7163.MCT-11-0594.
Article
CAS
PubMed
Google Scholar
Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM: Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol. 2009, 27: 3297-3302. 10.1200/JCO.2009.19.6410.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K: Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res. 2009, 69: 7507-7511. 10.1158/0008-5472.CAN-09-2994.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rattan R, Graham RP, Maguire JL, Giri S, Shridhar V: Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin in vivo. Neoplasia. 2011, 13: 483-491.
Article
CAS
PubMed
PubMed Central
Google Scholar
Janjetovic K, Vucicevic L, Misirkic M, Vilimanovich U, Tovilovic G, Zogovic N, Nikolic Z, Jovanovic S, Bumbasirevic V, Trajkovic V, Harhaji-Trajkovic L: Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt. Eur J Pharmacol. 2011, 651: 41-50. 10.1016/j.ejphar.2010.11.005.
Article
CAS
PubMed
Google Scholar
Palanimuthu D, Shinde SV, Somasundaram K, Samuelson AG: In vitro and in vivo anticancer activity of copper bis(thiosemicarbazone) complexes. J Med Chem. 2013, 56: 722-734. 10.1021/jm300938r.
Article
CAS
PubMed
Google Scholar
Donnelly PS, Liddell JR, Lima S, Paterson BM, Cater MA, Savva MS, Mot AI, James JL, Trounce IA, White AR, Crouch PJ: An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarnazonato)copperII. Proc Natl Acad Sci U S A. 2012, 109: 47-52. 10.1073/pnas.1116227108.
Article
CAS
PubMed
Google Scholar
French FA, Freedlander BL: Carcinostatic action of polycarbonyl compounds and their derivatives: IV. Glyoxal bis(thiosemicarbazone) and derivatives. Cancer Res. 1958, 18: 1290-1300.
CAS
PubMed
Google Scholar
Crowley AR, Dilworth JR, Donnelly PS, Gee AD, Heslop JM: Acetylacetone bis(thiosemicarbazone) complexes of copper and nickel: towards new copper radiopharmaceuticals. Dalton Trans. 2004, 2404-2412.
Google Scholar
Veale RB, Thornley AL: Increased single class low-affinity EGF receptors expressed by human oesophageal squamous carcinoma cell lines. S Afr J Sci. 1989, 85: 375-379.
Google Scholar
Bey E, Alexander J, Whitcutt JM, Hunt JA, Gear JH: Carcinoma of the esophagus in Africans: establishment of a continuously growing cell line from a tumor specimen. In Vitro. 1976, 12: 107-114. 10.1007/BF02796356.
Article
CAS
PubMed
Google Scholar
Liu B, Fang M, Lu Y, Fan Z: Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody. Oncogene. 2001, 20: 1913-1922. 10.1038/sj.onc.1204277.
Article
CAS
PubMed
Google Scholar
Brouwers EEM, Tibben MM, Pluim D, Rosing H, Boot H, Cats A, Schellens JHM, Beijnen JH: Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin. Anal Bioanal Chem. 2008, 391: 577-585. 10.1007/s00216-008-2034-8.
Article
CAS
PubMed
Google Scholar
Smith DJ, Cossins LR, Hatzinisiriou I, Haber M, Nagley P: Lack of correlation between MYCN expression and the Warburg effect in neuroblastoma cell lines. BMC Cancer. 2008, 8: 259-10.1186/1471-2407-8-259.
Article
PubMed
PubMed Central
Google Scholar
Damelin LH, Coward S, Choudhury SF, Chalmers S, Cox IJ, Robertson NJ, Revial G, Miles M, Tootle R, Hodgson HJF, Selden C: Altered mitochondrial function and cholesterol synthesis influences protein synthesis in extended HepG2 spheroid cultures. Arch Biochem Biophys. 2004, 434: 167-77.
Article
Google Scholar
Kosower NS, Kosower EM, Newton GL, Ranney HM: Bimane fluorescent labels: labelling of normal human red cells under physiological conditions. Proc Natl Acad Sci U S A. 1979, 79: 3382-3386.
Article
Google Scholar
Griffith OW: Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs potent inhibitors of glutathione synthesis. J Biol Chem. 1982, 257: 13704-13712.
CAS
PubMed
Google Scholar
Shaw RJ, Lamia K, Vasquez D, Koo S-H, Bardeesy N, Depinho R, Montminy M, Cantley LC: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005, 310: 1642-6. 10.1126/science.1120781.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lu SC: Regulation of glutathione synthesis. Mol Aspects of Med. 2009, 30: 42-59. 10.1016/j.mam.2008.05.005.
Article
CAS
Google Scholar
Zafarullaha M, Lia WQ, Sylvestera J, Ahmad M: Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003, 60: 6-20. 10.1007/s000180300001.
Article
Google Scholar
Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB: Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64: 3892-3899. 10.1158/0008-5472.CAN-03-2904.
Article
CAS
PubMed
Google Scholar
Jorgenson TC, Zhong W, Oberley TD: Redox imbalance and biochemical changes in cancer. Cancer Res. 2013, 73: 6118-6123. 10.1158/0008-5472.CAN-13-1117.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cairns R, Harris IS, Mak TW: Regulation of cancer cell metabolism. Nat Rev Cancer. 2011, 11: 85-95. 10.1038/nrc2981.
Article
CAS
PubMed
Google Scholar
Vander Heiden MG: Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discovery. 2011, 10: 671-84. 10.1038/nrd3504.
Article
CAS
PubMed
Google Scholar
Paz MM: Reductive activation of mitomycin C by thiols: kinetics, mechanism, and biological implications. Chem Res Toxicol. 2009, 22: 1663-1668. 10.1021/tx9002758.
Article
CAS
PubMed
Google Scholar
Paterson BM, Donnelly PS: Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals. Chem Soc Rev. 2011, 40: 3005-18. 10.1039/c0cs00215a.
Article
CAS
PubMed
Google Scholar
Tardito S, Marchiò L: Copper compounds in anticancer strategies. Curr Med Chem. 2009, 16: 1325-48. 10.2174/092986709787846532.
Article
CAS
PubMed
Google Scholar
Shankar LK: The clinical evaluation of novel imaging methods for cancer management. Nat Rev Clinical Oncology. 2012, 9: 738-744. 10.1038/nrclinonc.2012.186.
Article
CAS
PubMed
Google Scholar